Pfizer
AstraZeneca Covid booster shot effective against severe disease, UK study finds
London, May 5 (PTI) The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according…
S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills
SEOUL (Reuters) -South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the use of Novavax Inc's vaccine on Wednesday…
New Zealand approves Pfizer vaccine for children aged 5-11 years
By Praveen Menon WELLINGTON (Reuters) - New Zealand's health regulator Medsafe has granted provisional approval for the Pfizer Inc COVID-19 vaccine for children aged 5 to 11 years old, the…
Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations
By Francesco Guarascio BRUSSELS (Reuters) - Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of…
Joyful moment or risky move? Europe divided over kids’ vaccines
By Emilio Parodi, Nikolaj Skydsgaard and Bart H. Meijer MILAN/COPENHAGEN (Reuters) - As Europe starts vaccinating younger children, countries are pursuing very different strategies in what will be a major…
What leaders, health experts said about Pfizer’s COVID-19 pill
(Reuters) - A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing…
Saudi approves Pfizer’s COVID-19 vaccine for age group 5-11
CAIRO (Reuters) - The Saudi Food and Drug Authority said on Wednesday it had given its approval to use Pfizer's COVID-19 vaccine for those between five and eleven years of…
Switzerland recommends COVID-19 booster shots for over 65s, but not general population
BERLIN (Reuters) -Switzerland said on Tuesday it was recommending COVID-19 booster shots for people over 65 but not for the general population. The vaccinations would start from mid-November and should…
Moderna says its COVID-19 vaccine protective, safe in young children
By Manas Mishra (Reuters) -Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response in children aged six to 11 years and that it plans to submit…
EU drugs regulator to decide on Pfizer vaccine booster in early October
(Reuters) -The European Medicines Agency (EMA) aims to decide in early October whether to endorse a third dose of the Pfizer-BioNTech COVID-19 vaccine to be given half a year after…
Exclusive – EU regulator to decide on Pfizer booster at the start of October – source
By Emilio Parodi and Francesco Guarascio BRUSSELS (Reuters) - The European Medicines Agency (EMA) expects to decide in early October on the possible use of a booster dose of the…
Unvaccinated children suffering COVID impact, Americas health agency warns
By Anthony Boadle BRASILIA (Reuters) - As more adults get their COVID-19 vaccines, children who are not yet eligible for vaccination in most countries are representing a larger percentage of…
